GlassScriptPhysician profile
Matthew Skinner
NPI 1033672910
$5,819.33
in general payments reported to CMS, 2019-2025
11 companies · $4,831 in 2025
The $4,831 reported for 2025 was more than what 80% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $369 · 2024: $620 · 2025: $4,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952 · Travel and Lodging: $2,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,952.26 |
| Travel and Lodging | $2,867.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,682.17 | 2025 | |
| Smith+Nephew, INC. | $1,349.94 | 2025 | Fast-Fix, Novostitch |
| Stryker Corporation | $1,217.23 | 2023-2025 | Mako, Hoffmann, Core |
| Icotec Medical INC. | $833.94 | 2024-2025 | Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Miach Orthopaedics, INC. | $196.57 | 2025 | |
| Goode Surgical INC | $193.19 | 2025 | |
| Mimedx Group, INC. | $145.19 | 2024 | |
| Depuy Synthes Sales INC. | $123.65 | 2025 | Monovisc |
| Linvatec Corporation | $46.33 | 2025 | Biobrace 23mm |
| Pylant Medical | $23.82 | 2023 | |
| Heraeus Medical, LLC. | $7.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.